Safe practice for patients receiving anticoagulant therapy
Annette Lankshear Reader in health policy, Cardiff School of Nursing and Midwifery Studies, St Cadocs Hospital, Caerleon
Jonathan Simms Head of pharmacy and medicines management, Aneurin Bevan Health Board, Torfaen, Gwent
Jane Harden Director of postgraduate studies, Cardiff School of Nursing and Midwifery Studies, Cardiff University
Venous thrombolembolism, although largely preventable, continues to be a major cause of death in hospitalised patients. The anticoagulant drugs used to prevent and treat this condition require careful and knowlegeable management. Nurses working in acute and community settings have an important role in this process.
Nursing Standard.
24, 20, 47-55.
doi: 10.7748/ns2010.01.24.20.47.c8157
Correspondence
lankshearaj@cardiff.ac.uk
Peer review
This article has been subject to double blind peer review
Want to read more?
Already have access? Log in
or
3-month trial offer for £5.25/month
Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
- Unlimited access to all 10 RCNi Journals
- RCNi Learning featuring over 175 modules to easily earn CPD time
- NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
- Personalised newsletters tailored to your interests
- A customisable dashboard with over 200 topics
Subscribe
Alternatively, you can purchase access to this article for the next seven days.
Buy now
Are you a student? Our student subscription has content especially for you.
Find out more
